The Journal of Practical Medicine >

2024 , Vol. 40 >Issue 2: 169 - 173

DOI: https://doi.org/10.3969/j.issn.1006-5725.2024.02.008

Feature Reports：carcinoma of cervix

The expression of WDR5 in cervical cancer tissue and its relationship with clinical and pathological characteristics of patients

  • Pixi WEI ,
  • Yu DENG ,
  • Cailing ZHAO ,
  • Liu XU ,
  • Min ZHANG
Expand
  • People's Hospital Affiliated to Shandong First Medical University，Ji′nan 271119，China

Received date: 2023-04-25

  Online published: 2024-03-06

Fold

Abstract

Objective To investigate the expression of WD repeat-containing protein 5 （WDR5） in cervical cancer tissue and its relationship with clinical pathological characteristics and prognosis of patients. Methods 105 CA patients admitted to our hospital from January 2018 to March 2020 were included as the study subjects， the cancer tissue and adjacent tissue samples of patients were collected， Immunohistochemical staining and Western blot were used to detect the level of WDR5 in CA tissue and adjacent cancer tissues. Immunohistochemistry and Western blot were used to determine the level； Survival analysis was conducted using the Kaplan Meier method； The influencing factors of patient prognosis were analyzed through Cox regression. Results Among 105 CA tissue samples， the positive expression rate of WDR5 （WDR5 positive cases/total cancer tissue cases） was 68.57% （72/105）， which was higher than 22.86% （24/105） in adjacent cancer tissues （P < 0.05）； Compared to adjacent tissues （1.00 ± 0.11）， the expression level of WDR5 was higher in CA tissues （4.66 ± 0.98） （t = 38.030， P < 0.05）. The expression level of WDR5 is related to the degree of differentiation， TNM staging， and lymph node metastasis （P < 0.05）； The survival rate of WDR5 positive expression was 65.28% （47/72） lower than that of negative expression of 90.91% （30/33） （Log rank χ2 = 6.732， P = 0.009）； TNM staging， WDR5， degree of differentiation， and lymph node metastasis are all influencing factors for patient prognosis （P < 0.05）. Conclusion The expression of WDR5 is elevated in cervical cancer tissues， and its changes are closely related to TNM staging， differentiation， lymph node metastasis， and prognosis in cervical cancer patients.

Key words： cervical cancer; WD repeat-containing protein 5; prognosis; pathological characteristics

Cite this article

Pixi WEI , Yu DENG , Cailing ZHAO , Liu XU , Min ZHANG . The expression of WDR5 in cervical cancer tissue and its relationship with clinical and pathological characteristics of patients[J]. The Journal of Practical Medicine, 2024 , 40(2) : 169 -173 . DOI: 10.3969/j.issn.1006-5725.2024.02.008

References

1 SHI S， MA H Y， ZHANG Z G. Clinicopathological and prognostic value of STAT3/p-STAT3 in cervical cancer： A meta and bioinformatics analysis［J］. Pathol Res Pract， 2021， 227：153624. doi:10.1016/j.prp.2021.153624
2 YANG R， MA M， YU S， et al. High Expression of PAMR1 Predicts Favorable Prognosis and Inhibits Proliferation， Invasion， and Migration in Cervical Cancer［J］. Front Oncol， 2021， 11：742017. doi:10.3389/fonc.2021.742017
3 刘敏， 缪华珍， 黄菁. G蛋白偶联受体4、Ki-67、生存素与高危HPV感染的相关性及诊断宫颈癌价值［J］. 中国计划生育学杂志， 2022， 30（12）：2866-2869，2874. doi:10.3969/j.issn.1004-8189.2022.12.042
4 LI D， QIU B， CHEN X， et al. Expression of CYB5D2 is associated with epithelial-mesenchymal transition and survival rates in patients with cervical cancer［J］. Transl Cancer Res， 2020， 9（2）：1185-1194. doi:10.21037/tcr.2020.01.03
5 ZHOU L， WU H， BAI X， et al. O-Glycosylating Enzyme GALNT2 Predicts Worse Prognosis in Cervical Cancer［J］. Pathol Oncol Res， 2022， 28：1610554. doi:10.3389/pore.2022.1610554
6 CHEN X， XU J， WANG X， et al. Targeting WD Repeat-Containing Protein 5 （WDR5）： A Medicinal Chemistry Perspective［J］. J Med Chem， 2021， 64（15）：10537-10556. doi:10.1021/acs.jmedchem.1c00037
7 LI D， YU X， KOTTUR J， et al. Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic［J］. Oncogene， 2022， 41（24）：3328-3340. doi:10.1038/s41388-022-02340-8
8 WANG Y， CHEN A， ZHENG C， et al. miR-92a promotes cervical cancer cell proliferation， invasion， and migration by directly targeting PIK3R1［J］. J Clin Lab Anal， 2021， 35（8）：e23893. doi:10.1002/jcla.23893
9 ZIGRAS T， LENNOX G， WILLOWS K， et al. Early Cervical Cancer： Current Dilemmas of Staging and Surgery［J］. Curr Oncol Rep， 2017， 19（8）：51. doi:10.1007/s11912-017-0614-5
10 方艳惠， 康晓丽， 朱巧英， 等. miR-496靶向调控DCUN1D1抑制宫颈癌发生发展机制研究［J］. 实用医学杂志， 2022， 38（2）：139-144.
11 LIU Q， LIU S， WANG D. Overexpression of microRNA-21 decreased the sensitivity of advanced cervical cancer to chemoradiotherapy through SMAD7［J］. Anticancer Drugs， 2020， 31（3）：272-281. doi:10.1097/cad.0000000000000871
12 ZHAO J， CAO H， ZHANG W， et al. SOX14 hypermethylation as a tumour biomarker in cervical cancer［J］. BMC Cancer， 2021， 21（1）：675. doi:10.1186/s12885-021-08406-2
13 ZHANG W， CAO H， YANG J， et al. The identification and validation of EphA7 hypermethylation， a novel biomarker， in cervical cancer［J］. BMC Cancer， 2022， 22（1）：636. doi:10.1186/s12885-022-09653-7
14 ZHOU H， LI A， LI C， et al. The co-expression of CBX8 and PD-L1 and prognostic value in cervical cancer［J］. Medicine （Baltimore）， 2021， 100（34）：e27056. doi:10.1097/md.0000000000027056
15 张颖， 吴月玲. 宫颈癌的免疫治疗：精准医学的到来［J］. 实用医学杂志， 2022， 38（15）：1856-1859. doi:10.3969/j.issn.1006-5725.2022.15.002
16 王旭， 徐静， 王笑笑， 等. miR-218-5p靶向VEGFA基因促进宫颈癌HeLa细胞凋亡并抑制迁移［J］. 实用医学杂志， 2022， 38（15）：1878-1883. doi:10.3969/j.issn.1006-5725.2022.15.006
17 ZENG L， SUN X. Correlation of INHBA Overexpression with Pathological Features， Antitumor Immune Response and Clinical Prognosis in Cervical Cancer［J］. Medicina （Kaunas）， 2023， 59（3）：495. doi:10.3390/medicina59030495
18 LI Z， LIANG N， WANG N， et al. WDR5 is a prognostic biomarker of brain metastasis from non-small cell lung cancer［J］. Front Oncol， 2022， 12：1023776. doi:10.3389/fonc.2022.1023776
19 JI A， QIAN L， TIAN Z， et al. WDR5 promotes the proliferation of lung adenocarcinoma by inducing SOX9 expression［J］. Biomark Med， 2021， 15（17）：1599-1609. doi:10.2217/bmm-2021-0184
20 HUANG D， CHEN X， CHEN X， et al. WDR5 Promotes Proliferation and Correlates with Poor Prognosis in Oesophageal Squamous Cell Carcinoma［J］. Onco Targets Ther， 2020， 13：10525-10534. doi:10.2147/ott.s234773
21 YU X， LI D， KOTTUR J， et al. A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models［J］. Sci Transl Med， 2021， 13（613）：eabj1578. doi:10.1126/scitranslmed.abj1578
22 孙平， 徐俊. WDR5在肺腺癌中的表达和预后提示作用研究［J］. 浙江医学， 2021， 43（11）：1188-1191，1195. doi:10.12056/j.issn.1006-2785.2021.43.11.2021-376
23 CAI W L， CHEN J F， CHEN H， et al. Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation［J］. Elife， 2022， 11：e78163. doi:10.7554/elife.78163.sa0
24 沐超， 成莹， 王晓露， 等. c-Myc在宫颈癌中的分子机制的研究进展［J］. 肿瘤学杂志， 2021， 27（11）：961-966.
25 CHEN T， LI K， LIU Z， et al. WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways［J］. Mol Ther， 2021， 29（6）：2134-2150. doi:10.1016/j.ymthe.2021.02.017
26 SONG Z， LI H. Circ_0072995 drives cervical cancer development by regulating the miR-29a/WDR5 axis［J］. J Obstet Gynaecol， 2022， 42（7）：3342-3348. doi:10.1080/01443615.2022.2125294
Options
Outlines

/

〈 〉